5th DNA Repair/Replication Structures and Cancer Conference

June 7, 2022
No items found.

MNM Bioscience presents its participation in the fifth DNA Repair/Replication Structures & Cancer conference (27 Apr 2022 – 01 May 2022), where speakers will focus on presenting the structural and mechanistic insights of dynamic complexes, operating in DNA repair and replication, transcription and other cancer-relevant events.

The 5th conference covers the whole array of subspecialties in oncology, such as drug clinical trials, mutational signatures, DNA repair, immune response and other master keys to improve patient outcomes. In fact, DNA repair pathway complexes are often located at the interface of multiple processes that are critical to cancer progression, making their explanation of fundamental biological and medical importance, with huge implications for the development of new therapeutic strategies. Interesting lectures and poster sessions along with lively discussions will foster fruitful interactions, collaborations and insights. MNM’s CEO Pawel Zawadzki, PhD, will also participate in the roundtable, sharing his experience.

5th DNA Repair/Replication Structures and Cancer Conference
June 9, 2022

You may also like

BiO€QUITY Europe on 17-19 May 2021

MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients.

Greetings from ECML PKDD 2022!

Maciej Piernik presented one of our core algorithms at the European Conference on Machine Learning and Principles and Practice of Knowledge Discovery in Databases.

Europe Biobank Week 2021

Almost a week has passed since the Europe Biobank Week 2021, and yet we are still impressed! We have attended great lectures, in which the speakers approached the topic of biobanking from different perspectives.

Professor Wojciech Niedzwiedz is joining our Scientific Advisory Board

Professor Wojciech Niedzwiedz from the Institute of Cancer Research and one of the top leaders in the field, is joining our Scientific Advisory Board.